NewAmsterdam Pharma Company NV (NAMS) currently has a stock price of $25.31. The stock saw a sharp increase in the last trading session, hitting a high of $52.16 after opening at $25.31. The lowest recorded price for the day was $27.08 before it closed at $22.96.
The stock market performance of NewAmsterdam Pharma Company NV has been fairly unsteady.
52-week price history of NAMS Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. NewAmsterdam Pharma Company NV’s current trading price is -7.26% away from its 52-week high, while its distance from the 52-week low is 80.01%. The stock’s price range for this period has remained between $14.06 and $27.29. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.84 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.84 million over the last three months.
Financial Performance and Market Capitalization
NewAmsterdam Pharma Company NV (NAMS) has experienced a quarterly rise of 31.34% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.85B and boasts a workforce of 68 employees.
Analysts’ Ratings For NewAmsterdam Pharma Company NV
As of right now, 8 analysts are rating NewAmsterdam Pharma Company NV as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
NAMS Stock Stochastic Average
As of today, the raw stochastic average of NewAmsterdam Pharma Company NV over the last 50 days is at 0.28%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 7.16%. Further, the company’s Stochastic %K and %D values for the last 20 days were 8.63% and 13.89%, respectively.
NAMS Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a gain of 55.95%.However, over the last six months, we can see a weaker performance of 19.95%. Over the last 30 days, the price of NAMS has fallen by 14.94%. And in the last five days, it has surged by 18.94%.
